Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine vs Magnesium Sulfate for Hemodynamic Stability in Laparoscopic Gynecologic Surgeries
NCT07359560Not yet recruiting
- Sponsor
- Zagazig University
- Start
- Jan 2026
- Primary completion
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of Lidocaine Hydrochloride Injection, without epinephrine and magnesium sulfate in hemodynamic instability (3 arms), sponsored by Zagazig University. Primary endpoint: Mean Arterial Pressure at 6 months. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrinemagnesium sulfate
03
Conditions
hemodynamic instability
Beyond the preview
Go deeper on NCT07359560.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07359560.